Tag: Nucleic Acids and Gene Therapies in Neuromuscular Disorders

Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH) Nonalcoholic Steatohepatitis (NASH) has emerged as a significant health concern, driven by the global rise in obesity and diabetes. This chronic liver condition, characterized by fat accumulation, inflammation, and liver damage, is often underdiagnosed and presents considerable challenges in treatment. As the understanding of NASH evolves, so does the…

Nucleic Acids and Gene Therapies in Neuromuscular Disorders: Next-Generation Therapeutic Strategies Neuromuscular disorders (NMDs) encompass a broad range of conditions that affect the nerves and muscles, leading to debilitating symptoms such as muscle weakness, fatigue, and impaired mobility. These disorders, including Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), and amyotrophic lateral sclerosis (ALS), have…